Alternatively, carcinoma-derived proteins were found to activate the NLRP3 inflammasome, which resulted in FasL-mediated NK cell cytotoxicity against metastatic tumor cells and effective tumor suppression after IL-18 activation of NK cells (57). The gene discussed is NLRP3; the disease is neoplasm.